Why are anogenital warts diagnoses decreasing in the UK: Bivalent human papillomavirus (HPV) vaccine cross-protection or failure to examine?

Sexually Transmitted Infections

Volumn 90, Issue 8, 2014, Pages 587-

  Clarke, Emily ^a   Board, Christopher ^b   Patel, Natasha ^b   Atkinson, Lindsay ^b   Tulloch, Hugh ^b   Patel, Raj ^a,b  

^a ROYAL SOUTH HANTS HOSPITAL   (United Kingdom)

^b UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

WART VIRUS VACCINE;

BUDGET; CHLAMYDIA TRACHOMATIS; CONDYLOMA ACUMINATUM; CONSULTATION; CROSS PROTECTION; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 11; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 6; LETTER; MEDICAL RECORD; NEISSERIA GONORRHOEAE; PREVALENCE; SEXUAL HEALTH; SEXUALLY TRANSMITTED DISEASE; UNITED KINGDOM; URINALYSIS; VACCINATION; CONDYLOMATA ACUMINATA; DIAGNOSTIC ERROR; DIAGNOSTIC TEST; EPIDEMIOLOGY; IMMUNOLOGY; PROCEDURES; UTILIZATION;

CONDYLOMATA ACUMINATA; DIAGNOSTIC ERRORS; DIAGNOSTIC TESTS, ROUTINE; GREAT BRITAIN; HUMANS; PAPILLOMAVIRUS VACCINES; VACCINATION;

EID: 84910639592     PISSN: 13684973     EISSN: 14723263     Source Type: Journal    
DOI: 10.1136/sextrans-2013-051480     Document Type: Letter

References (4)

1. Public Health England. Table 11: Number and rates of anogenital warts diagnoses in England, 2003-2012. http://www.hpa.org.uk/webc/HPAwebFile/HPAweb-C/1296688631354 (assessed 12 Nov. 2013).
2. Ali H, Guy RJ, Wand H, et al. Decline in in-patient treatments of genital warts among young Australians following the national HPV vaccination program. BMC Infect Dis 2013;13:140.
3. Van De Velde N, Boily MC, Drolet M, et al. Population-level impact of the bivalent, quadrivalent, and nonavelent human papillomavirus vaccines. J Natl Cancer Inst 2012;104:1712-23.
4. Department of Health. 10 high impact changes for genitourinary medicine 48-hour access. 2006. http://www.medfash.org.uk/uploads/files/p17abl2pr784ajpp184muelf49r.pdf (assessed 12 Nov. 2013).